Chronic Lymphocytic Leukemia: Research

The Lymphoma Research Foundation (LRF) remains dedicated to finding a cure for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) through an aggressively-funded research program and by supporting the development of improved therapies for people living with the disease.

The Foundation's volunteer Scientific Advisory Board, comprised of 45 world-renowned lymphoma experts, guides the Foundation's research activities, seeking out the most innovative and promising lymphoma research projects for support, including the LRF CLL Initiative. This unique initiative brings together the world's leading CLL experts to exchange ideas on how to improve treatment options for individuals living with the disease.